Aileron Therapeutics (ALRN) Stock Chart & Stock Price History $4.12 +0.27 (+7.01%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aileron Therapeutics Stock Price Performance5 Day Performance+7.67%1 Month Performance+12.99%3 Month Performance+81.82%6 Month Performance-12.09%Year-To-Date Performance+31.21%1 Year Performance+241.88% Receive ALRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesAlgo Trading Is Here 🔥One trade alert each day backed by powerful technology, yours free. For $0 you can get access to one daily stock picked directly from StocksToTrade’s algo-powered system.>> Click here to sign up & get the next 🔥alert sent directly to your phone << ALRN Stock Chart for Thursday, October, 31, 2024 ALRN Chart by TradingView Aileron Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/30/2024$4.08$3.85-5.64%$4.08$3.46201,744 shs$83.22 million10/29/2024$4.02$4.08+1.49%$4.40$3.67184,849 shs$88.19 million10/28/2024$3.72$4.02+8.21%$4.06$3.55131,032 shs$86.89 million10/25/2024$3.72$3.71-0.27%$3.73$3.5674,468 shs$80.19 million10/24/2024$3.57$3.72+4.20%$3.72$3.3251,229 shs$80.41 million10/23/2024$3.74$3.57-4.55%$3.74$3.5434,402 shs$77.17 million Get the Latest News and Ratings for ALRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/22/2024$3.57$3.74+4.76%$3.81$3.55406,900 shs$80.84 million10/21/2024$3.62$3.57-1.38%$3.70$3.5633,845 shs$77.17 million10/18/2024$3.61$3.62+0.28%$3.65$3.5416,678 shs$78.25 million10/17/2024$3.70$3.61-2.43%$3.70$3.5634,098 shs$78.03 million10/16/2024$3.69$3.70+0.27%$3.71$3.6034,587 shs$79.98 million10/15/2024$3.59$3.69+2.79%$3.72$3.6012,420 shs$79.76 million10/14/2024$3.62$3.59-0.83%$3.70$3.4115,496 shs$77.60 million10/11/2024$3.40$3.62+6.47%$3.70$3.4216,706 shs$78.45 million10/10/2024$3.46$3.40-1.73%$3.57$3.2414,044 shs$73.49 million10/09/2024$3.44$3.46+0.58%$3.57$3.4026,804 shs$74.79 million10/08/2024$3.27$3.44+5.20%$3.59$3.2934,549 shs$74.36 million10/07/2024$3.55$3.27-7.89%$3.55$3.2134,264 shs$70.68 million10/04/2024$3.46$3.55+2.60%$3.69$3.3910,620 shs$76.73 million10/03/2024$3.33$3.46+3.90%$3.55$3.3154,139 shs$74.79 million10/02/2024$3.62$3.33-8.01%$3.63$3.3020,485 shs$71.98 million10/01/2024$3.54$3.62+2.26%$3.62$3.3414,952 shs$78.25 million09/30/2024$3.65$3.54-3.01%$3.65$3.2887,367 shs$76.52 million09/27/2024$3.59$3.65+1.67%$3.70$3.4185,200 shs$78.90 million09/26/2024$3.21$3.59+11.84%$3.60$3.1071,986 shs$77.60 million09/25/2024$3.36$3.21-4.46%$3.33$2.8661,223 shs$69.56 million09/24/2024$3.71$3.36-9.43%$3.72$3.3367,512 shs$72.63 million09/23/2024$3.73$3.71-0.54%$3.83$3.4880,358 shs$80.19 million09/20/2024$2.91$3.73+28.18%$3.74$2.94351,972 shs$80.62 million09/19/2024$2.65$2.91+9.81%$2.93$2.70789,511 shs$62.90 million09/18/2024$2.88$2.65-7.99%$2.87$2.6519,081 shs$57.28 million09/17/2024$2.79$2.88+3.23%$2.91$2.67183,923 shs$62.25 million09/16/2024$2.74$2.79+1.82%$2.85$2.6735,684 shs$60.46 million09/13/2024$2.86$2.74-4.20%$2.80$2.675,371 shs$59.38 million09/12/2024$2.88$2.86-0.69%$2.89$2.6898,892 shs$61.82 million09/11/2024$2.74$2.88+5.11%$2.88$2.648,098 shs$62.41 million09/10/2024$2.75$2.74-0.36%$2.78$2.6012,699 shs$59.38 million09/09/2024$2.80$2.75-1.79%$2.79$2.6049,635 shs$59.59 million09/06/2024$2.89$2.80-3.11%$2.88$2.5517,627 shs$60.52 million09/05/2024$2.79$2.89+3.58%$2.93$2.7444,604 shs$62.47 millionThis man believes TSLA will reach $500 a share… (Ad)Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link09/04/2024$2.70$2.79+3.33%$2.79$2.6138,562 shs$60.31 million09/03/2024$2.52$2.70+7.14%$2.75$2.5045,817 shs$58.36 million09/02/2024$2.52$2.52$2.52$2.2710,900 shs$54.61 million08/30/2024$2.35$2.52+7.23%$2.52$2.2710,918 shs$54.47 million08/29/2024$2.37$2.35-0.84%$2.40$2.2621,796 shs$50.80 million08/28/2024$2.42$2.37-2.07%$2.40$2.307,243 shs$51.23 million08/27/2024$2.46$2.42-1.63%$2.46$2.2917,647 shs$52.31 million08/26/2024$2.32$2.46+6.03%$2.49$2.2829,686 shs$53.17 million08/23/2024$2.51$2.32-7.57%$2.43$2.2050,814 shs$50.15 million08/22/2024$2.56$2.51-1.95%$2.61$2.4772,795 shs$54.25 million08/21/2024$2.40$2.56+6.67%$2.59$2.3757,652 shs$55.33 million08/20/2024$2.15$2.40+11.63%$2.44$2.1889,311 shs$51.88 million08/19/2024$1.89$2.15+13.76%$2.19$2.0159,191 shs$46.47 million08/16/2024$1.65$1.89+14.55%$1.96$1.6744,074 shs$40.85 million08/15/2024$1.85$1.65-10.81%$1.95$1.6164,101 shs$35.67 million08/14/2024$2.06$1.85-10.19%$2.12$1.85234,354 shs$39.99 million08/13/2024$1.93$2.06+6.74%$2.25$1.8086,672 shs$44.53 million08/12/2024$1.96$1.93-1.53%$2.18$1.8921,879 shs$41.72 million08/09/2024$2.00$1.96-2.00%$2.21$1.9617,919 shs$42.37 million08/08/2024$2.10$2.00-4.76%$2.25$1.9515,396 shs$43.23 million08/07/2024$2.42$2.10-13.22%$2.37$2.109,851 shs$45.39 million08/06/2024$2.25$2.42+7.56%$2.45$2.2390,859 shs$52.30 million08/05/2024$2.05$2.25+9.76%$2.25$1.8562,315 shs$48.62 million08/02/2024$2.17$2.05-5.53%$2.17$2.0022,244 shs$44.30 million08/01/2024$2.20$2.17-1.36%$2.34$2.1624,382 shs$46.89 million07/31/2024$2.31$2.20-4.76%$2.34$2.2019,252 shs$47.54 million07/30/2024$2.33$2.31-0.86%$2.35$2.2425,407 shs$49.92 million Related Companies PDS Biotechnology Stock Price Chart Unity Biotechnology Stock Price Chart Cumberland Pharmaceuticals Stock Price Chart biote Stock Price Chart Foghorn Therapeutics Stock Price Chart Design Therapeutics Stock Price Chart Inozyme Pharma Stock Price Chart ProQR Therapeutics Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart AC Immune Stock Price Chart Receive ALRN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALRN) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aileron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aileron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.